AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Association between myeloperoxidase levels and risk of coronary artery disease
Authors: Zhang, ZL Brennan, ML Fu, XM Aviles, RJ Pearce, GL Penn, MS Topol, EJ Sprecher, DL Hazen, SL
Citation: Zl. Zhang et al., Association between myeloperoxidase levels and risk of coronary artery disease, J AM MED A, 286(17), 2001, pp. 2136-2142
Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation
Authors: Denzler, KL Borchers, MT Crosby, JR Cieslewicz, G Hines, EM Justice, JP Cormier, SA Lindenberger, KA Song, W Wu, WJ Hazen, SL Gleich, GJ Lee, JJ Lee, NA
Citation: Kl. Denzler et al., Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation, J IMMUNOL, 167(3), 2001, pp. 1672-1682
Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species
Authors: MacPherson, JC Comhair, SAA Erzurum, SC Klein, DF Lipscomb, MF Kavuru, MS Samoszuk, MK Hazen, SL
Citation: Jc. Macpherson et al., Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species, J IMMUNOL, 166(9), 2001, pp. 5763-5772
Increased atherosclerosis in myeloperoxidase-deficient mice
Authors: Brennan, ML Anderson, MM Shih, DM Qu, XD Wang, XP Mehta, AC Lim, LL Shi, WB Hazen, SL Jacob, JS Crowley, JR Heinecke, JW Lusis, AJ
Citation: Ml. Brennan et al., Increased atherosclerosis in myeloperoxidase-deficient mice, J CLIN INV, 107(4), 2001, pp. 419-430
Eosinophil peroxidase oxidation of thiocyanate - Characterization of majorreaction products and a potential sulfhydryl-targeted cytotoxicity system
Authors: Arlandson, M Decker, T Roongta, VA Bonilla, L Mayo, KH MacPherson, JC Hazen, SL Slungaard, A
Citation: M. Arlandson et al., Eosinophil peroxidase oxidation of thiocyanate - Characterization of majorreaction products and a potential sulfhydryl-targeted cytotoxicity system, J BIOL CHEM, 276(1), 2001, pp. 215-224
Eosinophil peroxidase catalyzes bromination of free nucleosides and double-stranded DNA
Authors: Shen, ZZ Mitra, SN Wu, WJ Chen, YH Yang, YW Qin, J Hazen, SL
Citation: Zz. Shen et al., Eosinophil peroxidase catalyzes bromination of free nucleosides and double-stranded DNA, BIOCHEM, 40(7), 2001, pp. 2041-2051
Peroxidases inhibit nitric oxide (NO) dependent bronchodilation: Development of a model describing NO-peroxidase interactions
Authors: Abu-Soud, HM Khassawneh, MY Sohn, JT Murray, P Haxhiu, MA Hazen, SL
Citation: Hm. Abu-soud et al., Peroxidases inhibit nitric oxide (NO) dependent bronchodilation: Development of a model describing NO-peroxidase interactions, BIOCHEM, 40(39), 2001, pp. 11866-11875
Interrogation of heme pocket environment of mammalian peroxidases with diatomic ligands
Authors: Abu-Soud, HM Hazen, SL
Citation: Hm. Abu-soud et Sl. Hazen, Interrogation of heme pocket environment of mammalian peroxidases with diatomic ligands, BIOCHEM, 40(36), 2001, pp. 10747-10755
Isolevuglandin-protein adducts in humans: products of free radical-inducedlipid oxidation through the isoprostane pathway
Authors: Salomon, RG Batyreva, E Kaur, K Sprecher, DL Schreiber, MJ Crabb, JW Penn, MS DiCorleto, AM Hazen, SL Podrez, EA
Citation: Rg. Salomon et al., Isolevuglandin-protein adducts in humans: products of free radical-inducedlipid oxidation through the isoprostane pathway, BBA-MOL C B, 1485(2-3), 2000, pp. 225-235
Oxidation and atherosclerosis
Authors: Hazen, SL
Citation: Sl. Hazen, Oxidation and atherosclerosis, FREE RAD B, 28(12), 2000, pp. 1683-1684
Myeloperoxidase-generated oxidants and atherosclerosis
Authors: Podrez, EA Abu-Soud, HM Hazen, SL
Citation: Ea. Podrez et al., Myeloperoxidase-generated oxidants and atherosclerosis, FREE RAD B, 28(12), 2000, pp. 1717-1725
Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fattystreaks, intermediate lesions and advanced atherosclerotic lesions
Authors: Hazen, SL Gaut, JP Crowley, JR Hsu, FF Heinecke, JW
Citation: Sl. Hazen et al., Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fattystreaks, intermediate lesions and advanced atherosclerotic lesions, BIOCHEM J, 352, 2000, pp. 693-699
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
Authors: Febbraio, M Podrez, EA Smith, JD Hajjar, DP Hazen, SL Hoff, HF Sharma, K Silverstein, RL
Citation: M. Febbraio et al., Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice, J CLIN INV, 105(8), 2000, pp. 1049-1056
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
Authors: Podrez, EA Febbraio, M Sheibani, N Schmitt, D Silverstein, RL Hajjar, DP Cohen, PA Frazier, WA Hoff, HF Hazen, SL
Citation: Ea. Podrez et al., Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species, J CLIN INV, 105(8), 2000, pp. 1095-1108
Eosinophils generate brominating oxidants in allergen-induced asthma
Authors: Wu, WJ Samoszuk, MK Comhair, SAA Thomassen, MJ Farver, CF Dweik, RA Kavuru, MS Erzurum, SC Hazen, SL
Citation: Wj. Wu et al., Eosinophils generate brominating oxidants in allergen-induced asthma, J CLIN INV, 105(10), 2000, pp. 1455-1463
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species (vol 105, pg 1095, 2000)
Authors: Podrez, EA Febbraio, M Sheibani, N Schmitt, D Silverstein, RL Hajjar, DP Cohen, PA Frazier, WA Hoff, HF Hazen, SL
Citation: Ea. Podrez et al., Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species (vol 105, pg 1095, 2000), J CLIN INV, 105(10), 2000, pp. 1483-1483
Nitric oxide modulates the catalytic activity of myeloperoxidase
Authors: Abu-Soud, HM Hazen, SL
Citation: Hm. Abu-soud et Sl. Hazen, Nitric oxide modulates the catalytic activity of myeloperoxidase, J BIOL CHEM, 275(8), 2000, pp. 5425-5430
Nitric oxide is a physiological substrate for mammalian peroxidases
Authors: Abu-Soud, HM Hazen, SL
Citation: Hm. Abu-soud et Sl. Hazen, Nitric oxide is a physiological substrate for mammalian peroxidases, J BIOL CHEM, 275(48), 2000, pp. 37524-37532
p-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima
Authors: Heller, JI Crowley, JR Hazen, SL Salvay, DM Wagner, P Pennathur, S Heinecke, JW
Citation: Ji. Heller et al., p-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima, J BIOL CHEM, 275(14), 2000, pp. 9957-9962
Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical
Authors: Shen, ZZ Wu, WJ Hazen, SL
Citation: Zz. Shen et al., Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical, BIOCHEM, 39(18), 2000, pp. 5474-5482
Mass spectrometric analysis of pentafluorobenzyl oxime derivatives of reactive biological aldehydes
Authors: Hsu, FF Hazen, SL Giblin, D Turk, J Heinecke, JW Gross, ML
Citation: Ff. Hsu et al., Mass spectrometric analysis of pentafluorobenzyl oxime derivatives of reactive biological aldehydes, INT J MASS, 187, 1999, pp. 795-812
Modification of type IIIVLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity,causes marked cholesteryl ester accumulation in macrophages
Authors: Whitman, SC Hazen, SL Miller, DB Hegele, RA Heinecke, JW Huff, MW
Citation: Sc. Whitman et al., Modification of type IIIVLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity,causes marked cholesteryl ester accumulation in macrophages, ART THROM V, 19(5), 1999, pp. 1238-1249
Synthesis, isolation, and characterization of the adduct formed in the reaction of p-hydroxyphenylacetaldehyde with the amino headgroup of phosphatidylethanolamine and phosphatidylserine
Authors: Hazen, SL Heller, J Hsu, FF d'Avignon, A Heinecke, JW
Citation: Sl. Hazen et al., Synthesis, isolation, and characterization of the adduct formed in the reaction of p-hydroxyphenylacetaldehyde with the amino headgroup of phosphatidylethanolamine and phosphatidylserine, CHEM RES T, 12(1), 1999, pp. 19-27
Modification of proteins and lipids by myeloperoxidase
Authors: Hazen, SL Hsu, FF Gaut, JP Crowley, JR Heinecke, JW
Citation: Sl. Hazen et al., Modification of proteins and lipids by myeloperoxidase, METH ENZYM, 300, 1999, pp. 88-105
Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues
Authors: Heinecke, JW Hsu, FF Crowley, JR Hazen, SL Leeuwenburgh, C Mueller, DM Rasmussen, JE Turk, J
Citation: Jw. Heinecke et al., Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues, METH ENZYM, 300, 1999, pp. 124-144
Risultati: 1-25 | 26-31